Viana VG, Viana EG, Leal VL, et al. ORAL GLP-1 RECEPTOR AGONIST (ORFORGLIPRON) IN THE MANAGEMENT OF OBESITY AND TYPE 2 DIABETES. Editora. Published online January 13, 2026:43-55. Accessed March 4, 2026. https://sevenpubl.com.br/editora/article/view/8968